Hong Kong Life Sciences and Technologies Group Limited provides earnings guidance for the full year ended March 31, 2020. The company announced that based on information currently available to the Company, the Group is expected to record a loss attributable to owners of the Company of approximately HKD 220 million for the year ended 31 March 2020 as compared to a loss attributable to owners of the Company of approximately HKD 23 million for the year ended 31 March 2019.